Cartesian Therapeutics
RNAC
#6778
Rank
ยฃ0.37 B
Marketcap
ยฃ14.92
Share price
12.45%
Change (1 day)
-46.22%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -ยฃ0.2 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are ยฃ54.1 Million. In 2023 the company made an earning of -ยฃ0.19 Billion a decrease over its 2022 earnings that were of ยฃ30.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ0.2 Billion3.44%
2023 -ยฃ0.19 Billion-724%
2022 ยฃ30.17 M-649.67%
2021 -ยฃ5.49 Million-89.78%
2020 -ยฃ53.74 Million25.06%
2019 -ยฃ42.98 Million-15.68%
2018 -ยฃ50.97 Million-0.43%
2017 -ยฃ51.19 Million83.41%
2016 -ยฃ27.91 Million44.3%
2015 -ยฃ19.34 Million